HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prevalence and characteristics of pharyngeal group A beta-hemolytic streptococci in US Navy recruits receiving benzathine penicillin prophylaxis.

Abstract
US military recruits receive benzathine penicillin prophylaxis because of endemicity of group A beta-hemolytic streptococcal (GABHS) infections. GABHS prevalence in Navy recruits receiving single-dose benzathine penicillin prophylaxis was assessed during spring and fall 1989 by culturing throat specimens from randomly selected groups of approximately 230 men before and 2, 4, and 7 weeks after prophylaxis and from men with pharyngitis diagnosed at sick call. Of 60 GABHS isolates, 75% were serotype M-3. The pharyngitis rate increased from 0.18% in the spring to 1.55% in the fall with a concurrent increase in serotype M-3 prevalence from 35% to 91%. The GABHS prevalence rate was three- to fourfold lower after prophylaxis. There were no cases of acute rheumatic fever (ARF) despite predominance of M-3, a rheumatogenic serotype. It was concluded that penicillin prophylaxis continues to be effective for control of GABHS infections and prevention of ARF in Navy recruits.
AuthorsA D Heggie, M R Jacobs, P E Linz, D P Han, E L Kaplan, B Boxerbaum
JournalThe Journal of infectious diseases (J Infect Dis) Vol. 166 Issue 5 Pg. 1006-13 (Nov 1992) ISSN: 0022-1899 [Print] United States
PMID1402011 (Publication Type: Journal Article)
Chemical References
  • Penicillin G Benzathine
Topics
  • Drug Hypersensitivity
  • Humans
  • Male
  • Military Personnel
  • Penicillin G Benzathine (immunology, therapeutic use)
  • Pharyngitis (microbiology)
  • Pharynx (microbiology)
  • Prevalence
  • Serotyping
  • Streptococcal Infections (epidemiology, microbiology, prevention & control)
  • Streptococcus pyogenes (classification, isolation & purification)
  • United States

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: